Isotretinoin Use and Liver Enzymes Changes: A Single-Center Study in Saudi Arabia.

Autor:	Al Dhafiri M; Department of Dermatology, College of Medicine, King Faisal University, Al-Hofuf, SAU., Kaliyadan F; Department of Dermatology, Sree Narayana Institute of Medical Sciences, Ernakulam, IND., Almukhaimar S; Medical School, College of Medicine, King Faisal University, Al-Hofuf, SAU., Alsultan F; Medical School, College of Medicine, King Faisal University, Al-Hofuf, SAU., Al Hayim E; Medical School, College of Medicine, King Faisal University, Al-Hofuf, SAU., Alnaim R; Medical School, College of Medicine, King Faisal University, Al-Hofuf, SAU., Aldossari A; Medical School, College of Medicine, King Faisal University, Al-Hofuf, SAU.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2023 Dec 29; Vol. 15 (12), pp. e51263. Date of Electronic Publication: 2023 Dec 29 (Print Publication: 2023).
DOI:	10.7759/cureus.51263
Abstrakt:	Introduction Isotretinoin is a bioactive retinoic acid variant that is taken orally to treat moderate to severe acne vulgaris. One of the adverse effects of isotretinoin is elevated liver enzymes. This study estimated the prevalence of liver enzyme changes during isotretinoin use among dermatology clinic patients in Al-Ahsa, Kingdom of Saudi Arabia. Methods This study was a retrospective analysis that reviewed the medical data of 97 patients with acne at the King Faisal University Polyclinic who were taking systemic isotretinoin. It determined the baseline, second, and last readings of aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Among the 97 patients, 67 (69.1%) were female and 30 (30.9%) were male. Results Of the patients, 41 (50.6%) weighed 51-70 kg, and 45 (46.4%) were 21-23 years old. The age of acne onset was 20 years or younger. Most patients had a starting isotretinoin dose of 10-20 mg and an ending dose of 30-40 mg over six months. Ninety (92.8%) patients had not used isotretinoin in the past. Before treatment, AST was elevated in three (3.1%) patients, and ALT was elevated in two (2.1%) patients. In the last readings, AST was elevated in eight (8.2%) patients, and ALT was elevated in four (4.1%) patients. Conclusion The result of this study indicates that the incidence of high levels of AST and ALT with oral isotretinoin was low. So frequent laboratory monitoring is not recommended since the elevation was not associated with any morbidity and carries financial and emotional burdens. An exception is patients with higher body weight, males, and those whose acne started at age 16-19, in whom frequent monitoring may be considered for AST more than ALT. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2023, Al Dhafiri et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu